Xtant Medical Holdings, Inc. (XTNT): Market Cap to Revenue

Symbol and logo of brand Xtant Medical Inc (XTNT)

Xtant Medical Holdings (XTNT) revenue is based on the supply of spinal fixation systems to US clinics. The price-to-sales ratio trend confirms the stability of the business, where 0.30 determines the latest valuation metric. The low cyclicality of the surgical sector protects the company during crises, while scalability via a network of independent agents allows for the expansion of sales volumes without increasing headcount.

XTNT Xtant Medical Inc P/S Multiple (07/04/2022 - 11/18/2026)

Analytical breakdowns for Xtant Medical Holdings, Inc. (XTNT)

- stock exchange capitalization data:
General company analysis:XTNT Xtant Medical Holdings
Core merchandise of Xtant Medical

Xtant Medical Holdings (XTNT) is expanding its line of orthopedic implants and biologics through a systematic update of its R&D pipeline. This multiple compares market capitalization to generated revenue, allowing for an assessment of the cost per dollar of sales. It is critical for investors to monitor the gap between share price growth and actual earnings to avoid asset overvaluation. Analyzing the company's rolling P/S ratio helps identify abnormal deviations from the fundamental basis in a timely manner.

Competitors of Xtant Medical Holdings

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical - Market Cap to Sales Volume|VANI (Vivani Medical Inc) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)